These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8789061)
1. Correlation of the polysaccharide antigens of Francisella tularensis with virulence in experimental mice. Fujita H; Sato T; Watanabe Y; Ohara Y; Homma M Microbiol Immunol; 1995; 39(12):1007-9. PubMed ID: 8789061 [TBL] [Abstract][Full Text] [Related]
2. Correlation between the virulence of Francisella tularensis in experimental mice and its acriflavine reaction. Sato T; Fujita H; Ohara Y; Homma M Curr Microbiol; 1992 Aug; 25(2):95-7. PubMed ID: 1369194 [TBL] [Abstract][Full Text] [Related]
3. The entry and intracellular multiplication of Francisella tularensis in cultured cells: its correlation with virulence in experimental mice. Fujita H; Watanabe Y; Sato T; Ohara Y; Homma M Microbiol Immunol; 1993; 37(11):837-42. PubMed ID: 8295562 [TBL] [Abstract][Full Text] [Related]
4. [The C antigen of Francisella tularensis]. Sukhar' VV; Uraleva VS Mikrobiol Zh (1978); 1992; 54(2):42-6. PubMed ID: 1374833 [TBL] [Abstract][Full Text] [Related]
5. [The characteristics of a natural attenuated isolate of Francisella tularensis]. Kormilitsyna MI; Meshcheriakova IS Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):3-6. PubMed ID: 8701651 [TBL] [Abstract][Full Text] [Related]
6. [The capacity of avirulent forms of Francisella tularensis for dissemination and proliferation in the host body]. Tsimbalistova MV; Pavlovich NV; Sorokin VM; Tynkevich NK Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):10-3. PubMed ID: 8701638 [TBL] [Abstract][Full Text] [Related]
7. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751 [TBL] [Abstract][Full Text] [Related]
8. Virulence of representative Japanese Francisella tularensis and immunologic consequences of infection in mice. Hotta A; Fujita O; Uda A; Yamamoto Y; Sharma N; Tanabayashi K; Yamada A; Morikawa S Microbiol Immunol; 2016 Mar; 60(3):168-76. PubMed ID: 26853540 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model. Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073 [TBL] [Abstract][Full Text] [Related]
10. Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. Golovliov I; Kuoppa K; Sjöstedt A; Tärnvik A; Sandström G FEMS Immunol Med Microbiol; 1996 Mar; 13(3):239-44. PubMed ID: 8861036 [TBL] [Abstract][Full Text] [Related]
11. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Raynaud C; Meibom KL; Lety MA; Dubail I; Candela T; Frapy E; Charbit A Infect Immun; 2007 Jan; 75(1):536-41. PubMed ID: 17030571 [TBL] [Abstract][Full Text] [Related]
12. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Fulop M; Mastroeni P; Green M; Titball RW Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272 [TBL] [Abstract][Full Text] [Related]
13. Differential Substrate Usage and Metabolic Fluxes in Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859 [No Abstract] [Full Text] [Related]
14. Antigenic structure of tularemia microbe strains with different degrees of virulence. Meshcheryakova IS J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):446-56. PubMed ID: 4992903 [No Abstract] [Full Text] [Related]
16. Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice. Hartley G; Taylor R; Prior J; Newstead S; Hitchen PG; Morris HR; Dell A; Titball RW Vaccine; 2006 Feb; 24(7):989-96. PubMed ID: 16257097 [TBL] [Abstract][Full Text] [Related]
17. Virulence comparison in mice of distinct isolates of type A Francisella tularensis. Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801 [TBL] [Abstract][Full Text] [Related]